Seven recent developments regarding dermatitis
Recent developments involving dermatitis include the use of vitamin D supplementation to improve winter-related symptoms in children and the U.S. Food and Drug Administration granting breakthrough therapy designation to dupilumab for adults with ...
Healio - Wed, 17 Dec 2014 13:45



Topical steroid cream improves dermatitis in cancer patients
Dr. Lisa Wood from Lancaster Medical School said, “Mometasone furoate cream significantly reduces radiation dermatitis when applied to the breast during and after radiation therapy. For the first time, we have shown a significantly beneficial effect on ...
Science Codex - Sat, 13 Dec 2014 22:11



Guidelines for Adjunct, CAM Tx in Atopic Dermatitis Developed
(HealthDay News) — For patients with atopic dermatitis, adjunctive and complementary therapies are available, although evidence is limited for many of these approaches, according to guidelines published in the December issue of the Journal of the ...
Monthly Prescribing Reference - Thu, 11 Dec 2014 10:11

Guidelines Developed for Use of Adjunct Treatment in Atopic Dermatitis
HCPLive - Thu, 11 Dec 2014 16:00

Probiotics in Pregnancy, Lactation Reduce Dermatitis
ATLANTA — Probiotics should be consumed by pregnant and lactating women and their breast-fed infants to prevent the development of atopic dermatitis, according to recommendations that will soon be issued by the World Allergy Organization. "It will be ...
Medscape - Tue, 25 Nov 2014 12:39



Vitiligo, alopecia areata may up atopic dermatitis risk
The prevalence of atopic dermatitis is higher among patients with vitiligo or alopecia areata, according to research published online Dec. 3 in JAMA Dermatology. (HealthDay)—The prevalence of atopic dermatitis (AD) is higher among patients with ...
Medical Xpress - Fri, 05 Dec 2014 10:33

KindredBio Announces Update on AtoKin and Atopic Dermatitis Program
SAN FRANCISCO, Dec. 3, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. KIN, +0.91% a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has re-assessed its atopic dermatitis program and the atopic ...
MarketWatch - Wed, 03 Dec 2014 13:03

Kindred Bio exits atopic dermatitis, shares drop
Seeking Alpha - Thu, 04 Dec 2014 04:30

Kindred Biosciences (KIN) to Discontinue its AtoKin Study
StreetInsider.com (subscription) - Wed, 03 Dec 2014 13:21

Kindred dumps its dog eczema drug in another pipeline setback
FierceBiotech - Thu, 04 Dec 2014 06:57

US sales of Sanofi/Regeneron's dupilumab for atopic dermatitis could exceed ...
The first biologic to treat atopic dermatitis, French pharma major Sanofi (Euronext: SAN) and US biotech firm Regeneron Pharmaceuticals'(Nasdaq: REGN) dupilumab, could launch in the USA by second-quarter 2017. Moreover, the potentially ...
The Pharma Letter - Thu, 04 Dec 2014 08:30



Patients with vitiligo, alopecia areata at increased risk for atopic dermatitis
Girish C. Mohan, MD, and Jonathan I. Silverberg, MD, PhD, MPH, conducted a literature search of Medline, Embase, Cochrane Library, Google Scholar and 12 additional journals from 1946 to April 5, 2014, to compare the prevalence of atopic dermatitis (AD) ...
Healio - Tue, 09 Dec 2014 14:22


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014